Skip to main content
. 2021 Aug 13;10(18):6291–6303. doi: 10.1002/cam4.4171

FIGURE 1.

FIGURE 1

Kaplan–Meier analysis of PFS. (A) PFS rate for LIPI; (B) PFS rate for mLIPI; and (C) PFS rate for EPSILoN. PFS, progression‐free survival; LIPI, lung immune prognostic index; mLIPI, modified lung immune predictive index; EPSILoN, Eastern Cooperative Oncology Group performance status, smoking, liver metastases, lactate dehydrogenase, neutrophil‐to‐lymphocyte ratio